Ravelcare Halts Trading Window Ahead of FY26 Results

CONSUMER-PRODUCTS
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Ravelcare Halts Trading Window Ahead of FY26 Results
Overview

Ravelcare Limited has informed the BSE of its trading window closure for 'Designated Persons' and their 'Immediate Relatives,' effective April 1, 2026. The window will reopen 48 hours after the company announces its audited financial results for the half-year and full year ended March 31, 2026. The board meeting date for approving these results is pending announcement.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Ravelcare Closes Trading Window Ahead of FY26 Audited Results

Ravelcare Limited has officially notified the BSE that it is initiating a trading window closure. This restriction applies to all 'Designated Persons' within the company and their 'Immediate Relatives'.

The trading window will be shut starting April 1, 2026. It is scheduled to reopen 48 hours after the company formally announces its audited financial results for both the half-year and the full fiscal year ending March 31, 2026.

Ravelcare has yet to announce the specific date for the board meeting where these financial results will be reviewed and approved.

Purpose of the Closure

This closure is a standard regulatory measure in line with SEBI's Prohibition of Insider Trading Regulations. Its core aim is to prevent individuals with access to non-public, price-sensitive information from trading Ravelcare's shares. This practice ensures fair market conditions for all investors.

About Ravelcare

Founded in 2018, Ravelcare Limited is a digital-first beauty and personal care brand. The company made its debut on the BSE SME platform on December 8, 2025, following an Initial Public Offering (IPO) that raised ₹24.10 crore. Its shares listed at a significant 55% premium. For the fiscal year ending March 31, 2025 (FY25), Ravelcare reported revenue of ₹25.3 crore and a profit after tax (PAT) of ₹5.26 crore.

Impact on Employees and Shareholders

For Ravelcare's designated employees and their relatives, the immediate effect is a prohibition on buying or selling company shares during the specified closed period. Shareholders can view this as a sign that the company is moving towards its year-end financial reporting. They will be awaiting the upcoming results to assess Ravelcare's performance and growth trajectory.

Potential Risks

While the trading window closure itself is a routine compliance step, investors may become concerned if there is an unusual delay in the announcement of the financial results beyond the typical reporting timelines.

Competitive Landscape

Ravelcare operates within the competitive beauty and personal care sector. Its rivals include direct-to-consumer players like Honasa Consumer Ltd (Mamaearth) and FSN E Commerce Ventures Ltd (Nykaa), as well as established fast-moving consumer goods (FMCG) companies such as Marico Ltd. and Dabur India Ltd. The SEBI requirement for trading window closures before result announcements is a universal practice among listed Indian firms.

Next Steps

Investors should closely track Ravelcare Limited's upcoming announcements. Key events to monitor will be the notification of the board meeting date for approving the FY26 financial results, followed by the official disclosure of these results and the subsequent reopening of the trading window.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.